Arabic Arabic English English French French German German
dark

FDA and CDC lift recommended pause on Johnson & Johnson (Janssen) COVID-19 vaccine use following thorough safety review

FDAFollowing a thorough safety review, including two meetings of the CDC’s Advisory Committee on Immunization Practices, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Johnson & Johnson (Janssen) COVID-19 Vaccine in the U.S. should be lifted and use of the vaccine should resume.

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Campbell Wrapper Delivers Flow Wrappers to Web Industries for COVID-19 Tests and More Supplier News

Next Post

Seventeen South West trusts sign deal to support regional image sharing

Related Posts
Total
0
Share